Key result
In a rat model of controlled moderate aortic regurgitation, implanted decellularized conduit valves developed significant regurgitation (52±43%) and stenosis (14±10%) by 12 weeks.
This study establishes a small animal aortic conduit model with controlled moderate aortic regurgitation that allows for quantitative long-term echocardiographic assessment of implanted conduit valves.
Answers are grounded in this paper and cite their sources.
Valve failure in rat model cautions against clinical translation; extends small-animal platforms for conduit valve assessment.
BACKGROUND: The objective of this study was to describe a small animal aortic conduit model that could analyze long-term conduit valve (CV) function by echocardiography. METHODS AND RESULTS: Recipient Wistar rats (200-250g, n=20) underwent aortic leaflet injury of their native aortic valve under echocardiographic control. After 2 weeks, U-shaped decellularized CVs obtained from other rats were implanted onto the abdominal aorta. Implanted CVs were analyzed via pulsed-wave echocardiography at day 0, 4 and 12 weeks. CV stenosis was assessed as systolic flow velocity (post-pre CV)/flow velocity in the ascending aorta. CV regurgitation was assessed as the ratio of the amount of reversed diastolic flow to forward systolic flow in post-pre CV. The endpoint was set at 12 weeks. Three rats died immediately after aortic valve injury and all surviving rats received CV implantation (n=17, 85%). The survival rate after conduit implantation was 100% at 4 weeks and 88% (15/17) at 12 weeks. Regarding the CV function at 0, 4 and 12 weeks, the average observed value of CV stenosis was 3.8±7.9%, 3.1±4.1% and 14±10% (P<0.01), respectively. The average value of CV regurgitation was 0%, 12±27% and 52±43%, respectively (P<0.001). CONCLUSIONS: By using this model, the degeneration of implanted CV could be assessed not only qualitatively, but also quantitatively.
No takes yet. Share an insight, caveat, or question.
Munakata et al. (2013) studied Aortic regurgitation and conduit valve degeneration (n=20). Heterotopic aortic conduit valve implantation vs. Baseline (0 weeks) was evaluated on Conduit valve regurgitation at 12 weeks (p=<0.001). In a rat model of controlled moderate aortic regurgitation, implanted decellularized conduit valves developed significant regurgitation (52±43%) and stenosis (14±10%) by 12 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: